EUVIMEDEUVIMED entdecken
Crossref

Chondrocyte-targeted bilirubin/rapamycin carrier-free nanoparticles alleviate oxidative stress and modulate autophagy for osteoarthritis therapy

Huirong Huang, Xindan Liang, Shengjie Li, Yuqi Yan, Shize Li, Chenyu Qiu, Zhanzheng Ye, Yixuan Zhu, Dingchao Shen, Yinhao Lin, Luhui Wang, Nuo Chen und 7 weitere

Journal of Controlled Release · 2025

DOI: 10.1016/j.jconrel.2024.12.024 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Controlled Release, 2025. Verfasst von Huirong Huang und 18 weiteren Autor:innen. Beteiligte Einrichtung: Wenzhou Municipal Key Laboratory of Pediatric Pharmacy, Department of Pharmacy, The Second Affiliated Hospital and Yuying Children's Hospital of Wenz…. Hauptthemen laut MEDLINE: Chondrocytes, Osteoarthritis, Nanoparticles, Bilirubin. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: Zhejiang Province Natural Science Foundation, Health Commission of Zhejiang Province, Wenzhou Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Osteoarthritis (OA) is a prevalent chronic disease, characterized by the destruction of joint cartilage and synovitis, affects over 7 % of people worldwide. Disease-modifying treatments for OA still face significant challenges. Chondrocytes, as the exclusive cellular component of articular cartilage, play a pivotal role in synthesizing the intricate matrix of cartilage, thereby assuming a critical responsibility in facilitating its renewal and repair processes. However, oxidative stress within chondrocytes and subsequent apoptotic cell death plays significant roles in the progression of OA. Therefore, targeting apoptosis inhibition and mitigation of oxidative stress in chondrocytes represents a promising therapeutic strategy for OA. This study develops a type II collagen-targeting peptide (WYRGRLC) modified bilirubin/rapamycin carrier-free nanoparticle (PP/BRRP) and evaluate its therapeutic potential for OA. The PP/BRRP system exhibits remarkable chondrocyte-targeting ability, enabling the rupture of highly oxidized chondrocytes and subsequent release of bilirubin and rapamycin. This dual payload effectively scavenges reactive oxygen species, triggers autophagy, and suppresses the mTOR pathway, thereby augmenting anti-inflammatory and anti-apoptotic effects. The in vivo experiments further validate the retention and therapeutic efficacy of PP/BRRP in rat joints affected by OA. Overall, PP/BRRP exhibits significant potential for intervention and treatment of OA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ChondrocytesOsteoarthritisNanoparticlesBilirubinSirolimusAnimalsOxidative StressAutophagyRats, Sprague-DawleyMaleRatsHumansCollagen Type IIApoptosisReactive Oxygen SpeciesTOR Serine-Threonine Kinases

Stichwörter der Autor:innen

ApoptosisAutophagyBilirubinChondrocytesOsteoarthritisRapamycin

Substanzen

BilirubinSirolimusCollagen Type IIReactive Oxygen SpeciesTOR Serine-Threonine Kinases

Autor:innen und Institutionen

  • Wenzhou Municipal Key Laboratory of Pediatric Pharmacy, Department of Pharmacy, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou 325027, China; School of Pharmaceutica…
  • Wenzhou Municipal Key Laboratory of Pediatric Pharmacy, Department of Pharmacy, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou 325027, China; Pediatrics Discipline G…
  • Shanghai Key Laboratory of Maternal Fetal Medicine, Shanghai Institute of Maternal-Fetal Medicine and Gynecologic Oncology, Shanghai First Maternity and Infant Hospital, School of Medicine, Tongji University, Shanghai 2…
  • Wenzhou Municipal Key Laboratory of Pediatric Pharmacy, Department of Pharmacy, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou 325027, China.
  • Department of Pediatric, The First People's Hospital of Wenling, Taizhou, China.
  • Department of Pharmacy, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, China.

Förderung

  • Zhejiang Province Natural Science Foundation
  • Health Commission of Zhejiang Province
  • Wenzhou Medical University
  • National Natural Science Foundation of China

Zitieren

APA

Huang, H., Liang, X., Li, S., Yan, Y., Li, S., Qiu, C., Ye, Z., Zhu, Y., Shen, D., Lin, Y., Wang, L., Chen, N., Yao, Y., Zhao, X., Wu, F., Shi, X., Kou, L., Chen, R., & Yao, Q. (2025). Chondrocyte-targeted bilirubin/rapamycin carrier-free nanoparticles alleviate oxidative stress and modulate autophagy for osteoarthritis therapy. Journal of Controlled Release. https://doi.org/10.1016/j.jconrel.2024.12.024

Vancouver

Huang H, Liang X, Li S, Yan Y, Li S, Qiu C, et al. Chondrocyte-targeted bilirubin/rapamycin carrier-free nanoparticles alleviate oxidative stress and modulate autophagy for osteoarthritis therapy. Journal of Controlled Release. 2025. doi:10.1016/j.jconrel.2024.12.024

BibTeX
@article{Huang2025,
  author = {Huang, Huirong and Liang, Xindan and Li, Shengjie and Yan, Yuqi and Li, Shize and Qiu, Chenyu and Ye, Zhanzheng and Zhu, Yixuan and Shen, Dingchao and Lin, Yinhao and Wang, Luhui and Chen, Nuo and Yao, Yinsha and Zhao, Xinyu and Wu, Fugen and Shi, Xianbao and Kou, Longfa and Chen, Ruijie and Yao, Qing},
  title = {Chondrocyte-targeted bilirubin/rapamycin carrier-free nanoparticles alleviate oxidative stress and modulate autophagy for osteoarthritis therapy},
  journal = {Journal of Controlled Release},
  year = {2025},
  doi = {10.1016/j.jconrel.2024.12.024}
}
Kostenlos starten →